Respiratory Regeneration

MISSION: BREATHING BETTER

SURECELL REGENERATIVE PROTOCOL FOR CHRONIC LUNG DISEASE Lung diseases are some of the most common medical conditions in the world. Tens of millions of people suffer from lung disease. Smoking, infections, and genetics are responsible for most lung diseases. The lungs are part of a complex apparatus, expanding and relaxing thousands of times each day to bring in oxygen and expel carbon dioxide. Lung disease can result from problems in any part of this system. Chronic respiratory diseases, including Chronic Obstructive Pulmonary Disease (COPD) and asthma, are responsible for a substantial health and financial burden each year and one of the leading causes of death in the world. LUNG REGENERATION PROGRAM Lung Regeneration Program (LRP) is a regenerative cellular therapy to treat chronic lung disease, including chronic obstructive pulmonary disease (COPD), emphysema and chronic bronchitis. Many of these conditions have no cure, but certain treatments and measures can help patients breathe easier. Cellular therapy has allowed many people with chronic pulmonary conditions to improve their quality of life. PA-PRP FOR REGENERATION Although blood is mainly a liquid (called plasma), it also contains small solid components (red cells, white cells, and platelets.) The platelets are best known for their importance in clotting blood. However, platelets also contain hundreds of proteins called growth factors which are very important in the healing of injuries. PRP-PC (platelet-rich-plasma platelet-concentrate) is plasma with many more platelets than what is typically found in blood. The concentration of platelets — and, thereby, the concentration of growth factors — can be 4 to 6 times greater (or richer) than usual. DISEASES CAN BE TREATED (INDICATIONS):

• BRONCHIECTASIS
• CHRONIC BRONCHITIS
• CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
• EMPHYSEMA
• INTERSTITIAL LUNG DISEASE
• PULMONARY FIBROSIS